Home - International News - Novo Nordisk’s next obesity drug falls short of Lilly rival, wiping billions off its market value By Syndication Editor Feb 23, 2026 Novo Nordisk’s next obesity drug falls short of Lilly rival, wiping billions off its market value International News 5 Total views No comments Syndication Editor Related Posts The Fed is set to cut interest rates. Here are the risks As a financial expert, I taught all my kids the secret to building wealth: It’s not about how much money you make Comments (No) Leave a Reply Cancel Reply Save my name, email, and website in this browser for the next time I comment. Hide Comments
As a financial expert, I taught all my kids the secret to building wealth: It’s not about how much money you make
Comments (No)